Mizuho’s Dan Dolev is ‘super excited’ about this fintech stock

Robinhood Markets Inc (NASDAQ: HOOD) has been a nightmare for its investors this year but a Mizuho analyst is convinced that it’ll be a different story for those that choose to own it down here. Why i...

Crypto Is Dead, Says Mizuho’s Senior Analyst

Alex Dovbnya Dan Dolev, senior analyst at Mizuho Americas, is convinced that the cryptocurrency industry won’t be able to recover from the current crisis Dan Dolev, senior analyst at Mizuho Amer...

Mizuho’s Vamil Divan reveals his top biotech pick

AbbVie Inc (NYSE: ABBV) closed 2021 with a 25% gain in the stock price, and Mizuho’s senior biopharmaceuticals research analyst says 2022 will be another year of outperformance for the biotech giant. ...